Skip to main content

Table 2 Univariate Analysis of Clinical Outcome As A Function of MIBC By Quartile

From: The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer

Quartile

N

FFBF

FFM

CSS

OS

5 yr

8 yr

5 yr

8 yr

5 yr

8 yr

5 yr

8 yr

<10%

144

91%

91%

97%

95%

100%

96%

91%

72%

  

(88–94)

(88–94)

(95–99)

(92–98)

 

(93–99)

(88–94)

(55–79)

<30%

134

93%

79%

97%

93%

100%

100%

96%

92%

  

(90–96)

(72–86)

(95–99)

(88–98)

  

(94–98)

(89–95)

<70%

147

82%

70%

95%

83%

99%

99%

95%

82%

  

(88–86)

(63–77)

(93–97)

(77–89)

(98–100)

(98–100)

(93–97)

(77–87)

70 +%

164

74%

51%

91%

82%

94%

94%

87%

77%

  

(71–78)

(43–59)

(88–94)

(77–87)

(92–96)

(92–96)

(84–90)

(72–82)

p-value Overall

<0.0001

0.0047

0.0071

0.061

p-value Quartiles 1-3

0.009

0.12

0.29

0.30

  1. Rates at five and eight years along with the standard error of the mean.